Medullary Thyroid Carcinoma: New Therapies and Trials Matthew D. Ringel, MD Ralph W. Kurtz Chair and Professor of Medicine Director, Division of Endocrinology, Diabetes, and Metabolism The Ohio State University College o - The Ohio State University College of Medicine - Document - PDFSEARCH.IO

First Page	Meta Content
	Medullary Thyroid Carcinoma: New Therapies and Trials Matthew D. Ringel, MD Ralph W. Kurtz Chair and Professor of Medicine Director, Division of Endocrinology, Diabetes, and Metabolism The Ohio State University College o Add to Reading List Document Date: 2014-01-11 17:19:53 Open Document File Size: 534,15 KB Share Result on Facebook Country United States / / Facility Metabolism The Ohio State University College / / MedicalCondition metastatic disease / tumor / aggressive disease / Thyroid Carcinoma / Does FDG Uptake Predict Aggressive Disease / et al Cancer / metastases / thyroid cancer / Medullary Thyroid Carcinoma / Distant Metastases / Diabetes / / MedicalTreatment chemotherapy / / Organization National Institute of Health / The Ohio State University College of Medicine / AMERICAN THYROID ASSOCIATION / / Person Matthew D. Ringel / Ralph W. Kurtz / / Position Director Thyroid Cancer Unit Arthur G. James Cancer Center PRESENTATION / Chair and Professor of Medicine Director / Division of Endocrinology / / ProvinceOrState Ohio / / PublishedMedium Endocrinology / / Technology chemotherapy / / SocialTag Medicine Thyroid disease Medullary thyroid cancer Calcitonin Thyroid American Thyroid Association Pentagastrin-stimulated calcitonin test Thyroid cancer Anatomy Endocrinology

Medullary Thyroid Carcinoma: New Therapies and Trials Matthew D. Ringel, MD Ralph W. Kurtz Chair and Professor of Medicine Director, Division of Endocrinology, Diabetes, and Metabolism The Ohio State University College oAdd to Reading List